# US 2026/0098037 A1 · Compound containing multi-fused ring structure

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0098037 A1
- Document ID: US20260098037A1
- Status: Published application
- Kind: A1
- Application number: 19/336,376
- Filed: 2025-09-22
- Published: 2026-04-09
- Earliest claimed: 2023-06-30
- Assignees: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Applicants: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Inventors: Baomin Liu; Yan Zhu; Jinfa Hu; Yu Huang
- Web page: https://patentgrep.com/patent/US20260098037A1

## CPC

- C07D 471/04: Ortho-condensed systems
- A61K 31/437: the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
- A61K 31/4985: Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
- A61P 3/06: Antihyperlipidemics
- A61P 3/10: for hyperglycaemia, e.g. antidiabetics
- C07B 59/002: {Heterocyclic compounds}
- C07D 401/14: containing three or more hetero rings
- C07D 405/14: containing three or more hetero rings
- C07D 487/04: Ortho-condensed systems
- C07D 498/04: Ortho-condensed systems
- C07D 513/04: Ortho-condensed systems
- C07D 519/00: Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07B: GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR (preparation of carboxylic acid esters by telomerisation C07C67/47; telomerisation C08F)

## Abstract

The present invention is in the field of pharmaceutical chemistry, and relates to a compound containing a multi-fused ring structure, specifically to a compound of formula (I), a stereoisomer or pharmaceutically acceptable salt thereof, a preparation method therefor, or a pharmaceutical composition thereof, and a use thereof in the preparation of a drug for treating diabetes or obesity-related diseases.

## Claims

### Claim at position 1

1-20. (canceled)

### Claim 21

A compound selected from the group consisting of
or a pharmaceutically acceptable salt thereof.

### Claim 22 (depends on 21)

The compound of claim 21, wherein the compound is
or a pharmaceutically acceptable salt thereof.

### Claim 23 (depends on 21)

The compound of claim 21, wherein the compound is
or a pharmaceutically acceptable salt thereof.

### Claim 24 (depends on 21)

The compound of claim 21, wherein the compound is
or a pharmaceutically acceptable salt thereof.

### Claim 25 (depends on 21)

The compound of claim 21, wherein the compound is
or a pharmaceutically acceptable salt thereof.

### Claim 26 (depends on 21)

The compound of claim 21, wherein the compound is
or a pharmaceutically acceptable salt thereof.

### Claim 27 (depends on 21)

The compound of claim 21, wherein the compound is
or a pharmaceutically acceptable salt thereof.

### Claim 28 (depends on 21)

A pharmaceutical composition comprising the compound according to claim 21 or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable excipient.

### Claim 29 (depends on 22)

A pharmaceutical composition comprising the compound according to claim 22 or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable excipient.

### Claim 30 (depends on 23)

A pharmaceutical composition comprising the compound according to claim 23 or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable excipient.

### Claim 31 (depends on 24)

A pharmaceutical composition comprising the compound according to claim 24 or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable excipient.

### Claim 32 (depends on 25)

A pharmaceutical composition comprising the compound according to claim 25 or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable excipient.

### Claim 33 (depends on 26)

A pharmaceutical composition comprising the compound according to claim 26 or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable excipient.

### Claim 34 (depends on 27)

A pharmaceutical composition comprising the compound according to claim 27 or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable excipient.
